Mineralys Therapeutics, Inc. (MLYS) ownership: Top institutional holder: Catalys Pacific, LLC ($214.11M). Insider activity: Net Seller (0 buys, 20 sells). SEC EDGAR first-party data.
| Holder | Shares | Market Value | Reported |
|---|---|---|---|
| Catalys Pacific, LLC | 7903838.00 | $214.11M | 2026-03-31 |
| RA CAPITAL MANAGEMENT, L.P. | 7692750.00 | $208.40M | 2026-03-31 |
| SAMSARA BIOCAPITAL, LLC | 5871018.00 | $159.05M | 2026-03-31 |
| FMR LLC | 4861104.00 | $131.69M | 2026-03-31 |
| VANGUARD GROUP INC | 3352880.00 | $121.68M | 2025-12-31 |
| BlackRock, Inc. | 4481582.00 | $121.41M | 2026-03-31 |
| WELLINGTON MANAGEMENT GROUP LLP | 3359068.00 | $91.00M | 2026-03-31 |
| STATE STREET CORP | 2935940.00 | $79.53M | 2026-03-31 |
| Insider | Transaction | Value | Date |
|---|---|---|---|
| Sell | null | 2026-06-10 | |
| Sell | null | 2026-06-10 | |
| Sell | null | 2026-06-10 | |
| Sell | null | 2026-06-10 | |
| Sell | null | 2026-06-10 | |
| Sell | null | 2026-06-10 | |
| Sell | null | 2026-05-18 | |
| Sell | null | 2026-05-18 |
Back to MLYS overview · MLYS earnings · All congressional trades
Institutional data from SEC Form 13F. Insider data from SEC Form 4. Congressional data from STOCK Act disclosures. Not personalized investment advice.